We use cookies for a better user experience. Read our Privacy Policy

I Agree

Vaccines Market Forecast Report, 2017-2025

Vaccines Market (Vaccine Type - Inactivated, Live Attenuated, Toxoid, Conjugate; Valance - Monovalent, Multivalent; Route of Administration - Oral, Injectable; Indication - Influenza, Hepatitis, Polio, Meningococcal Disease, Pneumococcal Disease, DTP, Rotavirus, MMR, Human Papilloma Virus; Distribution Channel - Institutional Sales, Hospital Pharmacies, Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Vaccines Market: Overview

Rising developments in the medical therapy and disease prevention field are estimated to help the global vaccines market to expand at a CAGR of 6% during the forecast period of 2017 to 2025. Hence, the market for vaccines is projected to gain a valuation of US$ 48.0 Bn by 2025.

The report by Transparency Market Research (TMR) offers in-depth study of different factors impacting the growth of the global vaccines market. Thus, this document provides comprehensive assessment of factors such as expansion opportunities, growth drivers, restraints, challenges, and key regions in the market for vaccines. Furthermore, it enlightens readers on present and historical trends and ongoing research activities in the industry.

The experts at TMR have performed the segmentation of the global vaccines market on the basis of many crucial facets including vaccine, valance, route of administration, indication, distribution channel, and region. In terms of valance, the market is classified into monovalent and multivalent. Based on route of administration, the segmentation of the vaccines market is performed into three main parts, namely, injectable, oral, and others.

Hepatitis, influenza, meningococcal disease, polio, DTP, pneumococcal disease, MMR, human papilloma virus, and rotavirus are some of the diseases for prevention of in which vaccines are used. Different types of vaccines including live attenuated, inactivated, conjugate, and toxoid are available at distribution channels such as hospital pharmacies, retail pharmacies, and institutional sales.

With the ongoing rapid changes in the healthcare industry globally, organizations in the industry are not being limited to provide diagnosis of and treatment for different diseases, they are also playing important role in spreading awareness on the importance of vaccination. This factor is resulting in growing number of vaccination drives in many nations, and thereby boosting the demand for vaccines from all across the globe.

global vaccines market

Increase in Cases of Coronavirus Disease Boosts Sales in Vaccines Market

The emergence of COVID-19 pandemic has resulted into disruption in day-to-day activities of people from across the globe. The steep rise in the number of people infected with coronavirus has highlighted the need for development of novel and advanced vaccines that can help in the disease prevention. Thus, government as well as non-government organizations globally have increased financial support to researches, which are focused on the development of more effective vaccines to prevent the coronavirus spread. This factor is boosting the sales growth in the global vaccines market.

Market to Observe Prominent Growth Prospects in the U.S. and Asia Pacific

North America, Europe, Asia Pacific, Latin America, and Middle East and Africa are some of the prominent regions in the global vaccines market. Among all, countries such as the U.S. are estimated to play key part in the expansion of the vaccines market owing to developments in the healthcare industry and ongoing medical research activities in the country.

The market is prognosticated to gain revenue-generation opportunities in Asia Pacific. Governments of many regional nations such as India are growing efforts to prevent the occurrence of many diseases such as measles, small pox, and polio. Thus, they are organizing vaccination camps for these diseases, which in turn, is creating demand for vaccines in this country.

Companies Focus on Investing in R&D Projects to Stay Ahead in Competition

The list of key players operating in the vaccines market includes Janssen Pharmaceutical Company, CSL Ltd, Pfizer, Inc., GlaxoSmithKline plc., Sanofi Pasteur SA, and Mitsubishi Tanabe Pharma Corporation.

The presence of many international-level players in the vaccines market makes its competition landscape highly intense, which is promoting companies to use different strategies such as mergers, acquisitions, joint ventures, partnerships, and collaborations in order to stay ahead in the competition. Furthermore, companies are increasing investments in R&D projects.

Players in the vaccines industry are performing their regular activities while following all safety norms implemented by the regional government bodies. Moreover, they are also focused on strengthening their production capabilities to cater to the rising demand for coronavirus vaccines from all across the globe.

The vaccines market has been segmented as follows:

Vaccine

  • Inactivated
  • Live Attenuated
  • Toxoid
  • Conjugate
  • Others

Valance

  • Monovalent
  • Multivalent

Route of Administration

  • Oral
  • Injectable
    • Intramuscular
    • Subcutaneous
  • Others

Indication

  • Influenza
  • Hepatitis
  • Polio
  • Meningococcal Disease
  • Pneumococcal Disease
  • DTP
  • Rotavirus
  • MMR
  • Human Papilloma Virus
  • Others

Distribution Channel

  • Institutional Sales
  • Hospital Pharmacies
  • Retail Pharmacies

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC countries
    • Rest of MEA
Vaccines Market Forecast Report, 2017-2025

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of vaccines market?

Vaccines market is projected to reach US$ 48.0 Bn by 2025-end

What is the anticipated CAGR of the vaccines market in the forecast period?

Vaccines market is anticipated to expand at a CAGR of 6.0% during the forecast period

What are the key driving factors for the growth of the vaccines market?

The demand within the global market for vaccines has been rising on account of advancements in the field of medical therapy and disease prevention

What are the segments covered in the vaccines market?

TMR has segmented the vaccines market by Vaccine Type (Inactivated, Live Attenuated, Toxoid, and Conjugate), Valance (Monovalent, Multivalent), Route of Administration (Oral, Injectable) and geographic (North America, Europe, Asia Pacific, Latin America and MEA)

Who are the key players in the global vaccines market?

Key players operating in the global vaccines market include CSL Ltd, Janssen Pharmaceutical Company, GlaxoSmithKline plc., Pfizer, Inc., Mitsubishi Tanabe Pharma Corporation, and Sanofi Pasteur SA

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Vaccines Market

4. Market Overview
     4.1. Introduction
            4.1.1. Vaccine Type Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Vaccines Market Analysis and Forecasts, 2015–2025
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Market Outlook
     4.6.Key Market Trends
     4.7.Global Disease Epidemiology Overview, By Key Indications
     4.8.Pipeline Analysis
     4.9.Unmet Needs Analysis
     4.10.Pricing Analysis
     4.11.Institutional Sales Overview, by Volume (No. of Unit Dose)

5. Global Vaccines Market Analysis and Forecasts, By Vaccine Type
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Market value Forecast By Vaccine Type, 2015–2025
            5.3.1. Live Attenuated
            5.3.2. Inactivated
            5.3.3. Subunit & Conjugate
            5.3.4. Toxoid
            5.3.5. Others
     5.4. Market Attractiveness By Vaccine Type

6. Global Vaccines Market Analysis and Forecasts, By Valance
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market value Forecast By Valance, 2015–2025
            6.3.1. Monovalent
            6.3.2. Multivalent
     6.4. Market Attractiveness By Valance

7. Global Vaccines Market Analysis and Forecasts, By Route of Administration
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market value Forecast By Route of Administration, 2015–2025
            7.3.1. Oral
            7.3.2. Injectable
                     7.3.2.1. Intramuscular
                     7.3.2.2. Subcutaneous
            7.3.3. Others
     7.4. Market Attractiveness By Route of Administration

8. Global Vaccines Market Analysis and Forecasts, By Indication
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market value Forecast By Indication, 2015–2025
            8.3.1. Influenza
            8.3.2. Hepatitis
            8.3.3. Polio
            8.3.4. Meningococcal Disease
            8.3.5. Pneumococcal Disease
            8.3.6. DTP
            8.3.7. Rotavirus
            8.3.8. MMR
            8.3.9. Human Papilloma Virus
            8.3.10. Others
     8.4. Market Attractiveness By Indication

9. Global Vaccines Market Analysis and Forecasts, By Distribution Channel
     9.1. Introduction & Definition
     9.2. Key Findings / Developments
     9.3. Market value Forecast By Distribution Channel, 2015–2025
            9.3.1. Institutional Sale
            9.3.2. Hospital Pharmacies
            9.3.3. Retail Pharmacies
     9.4. Market Attractiveness By Distribution Channel

10. Global Vaccines Market Analysis and Forecasts, By Region
     10.1.Key Findings
     10.2.Market value Forecast By Region
            10.2.1. North America
            10.2.2. Europe
            10.2.3. Asia Pacific
            10.2.4. Latin America
            10.2.5. Middle East & Africa
     10.3.Market Attractiveness By Region

11. North America Vaccines Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
            11.1.2. Policies and Regulations
     11.2.Market value Forecast By Vaccine Type, 2015–2025
            11.2.1. Live Attenuated
            11.2.2. Inactivated
            11.2.3. Subunit & Conjugate
            11.2.4. Toxoid
            11.2.5. Others
     11.3.Market value Forecast By Valance, 2015–2025
            11.3.1. Monovalent
            11.3.2. Multivalent
     11.4.Market value Forecast By Route of Administration, 2015–2025
            11.4.1. Oral
            11.4.2. Injectable
                     11.4.2.1. Intramuscular
                     11.4.2.2. Subcutaneous
            11.4.3. Others
     11.5.Market value Forecast By Indication, 2015–2025
            11.5.1. Influenza
            11.5.2. Hepatitis
            11.5.3. Polio
            11.5.4. Meningococcal Disease
            11.5.5. Pneumococcal Disease
            11.5.6. DTP
            11.5.7. Rotavirus
            11.5.8. MMR
            11.5.9. Human Papilloma Virus
            11.5.10. Others
     11.6.Market value Forecast By Distribution Channel, 2015–2025
            11.6.1. Institutional Sale
            11.6.2. Hospital Pharmacies
            11.6.3. Retail Pharmacies
     11.7.Market value Forecast By Country, 2015–2025
            11.7.1. US
            11.7.2. Canada
     11.8.Market Attractiveness Analysis
            11.8.1. By Vaccine Type
            11.8.2. By Valance
            11.8.3. By Route of Administration
            11.8.4. By Indication
            11.8.5. By Distribution Channel
            11.8.6. By Country

12. Europe Vaccines Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
            12.1.2. Policies and Regulations
     12.2.Market value Forecast By Vaccine Type, 2015–2025
            12.2.1. Live Attenuated
            12.2.2. Inactivated
            12.2.3. Subunit & Conjugate
            12.2.4. Toxoid
            12.2.5. Others
     12.3.Market value Forecast By Valance, 2015–2025
            12.3.1. Monovalent
            12.3.2. Multivalent
     12.4.Market value Forecast By Route of Administration, 2015–2025
            12.4.1. Oral
            12.4.2. Injectable
                     12.4.2.1. Intramuscular
                     12.4.2.2. Subcutaneous
            12.4.3. Others
     12.5.Market value Forecast By Indication, 2015–2025
            12.5.1. Influenza
            12.5.2. Hepatitis
            12.5.3. Polio
            12.5.4. Meningococcal Disease
            12.5.5. Pneumococcal Disease
            12.5.6. DTP
            12.5.7. Rotavirus
            12.5.8. MMR
            12.5.9. Human Papilloma Virus
            12.5.10. Others
     12.6.Market value Forecast By Distribution Channel, 2015–2025
            12.6.1. Institutional Sale
            12.6.2. Hospital Pharmacies
            12.6.3. Retail Pharmacies
     12.7.Market value Forecast By Country / Sub-region, 2015–2025
            12.7.1. Germany
            12.7.2. UK
            12.7.3. France
            12.7.4. Italy
            12.7.5. Spain
            12.7.6. Rest of Europe
     12.8.Market Attractiveness Analysis
            12.8.1. By Vaccine Type
            12.8.2. By Valance
            12.8.3. By Route of Administration
            12.8.4. By Indication
            12.8.5. By Distribution Channel
            12.8.6. By Country / Sub-region

13. Asia Pacific Vaccines Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
            13.1.2. Policies and Regulations
     13.2.Market value Forecast By Vaccine Type, 2015–2025
            13.2.1. Live Attenuated
            13.2.2. Inactivated
            13.2.3. Subunit & Conjugate
            13.2.4. Toxoid
            13.2.5. Others
     13.3.Market value Forecast By Valance, 2015–2025
            13.3.1. Monovalent
            13.3.2. Multivalent
     13.4.Market value Forecast By Route of Administration, 2015–2025
            13.4.1. Oral
            13.4.2. Injectable
                     13.4.2.1. Intramuscular
                     13.4.2.2. Subcutaneous
            13.4.3. Others
     13.5.Market value Forecast By Indication, 2015–2025
            13.5.1. Influenza
            13.5.2. Hepatitis
            13.5.3. Polio
            13.5.4. Meningococcal Disease
            13.5.5. Pneumococcal Disease
            13.5.6. DTP
            13.5.7. Rotavirus
            13.5.8. MMR
            13.5.9. Human Papilloma Virus
            13.5.10. Others
     13.6.Market value Forecast By Distribution Channel, 2015–2025
            13.6.1. Institutional Sale
            13.6.2. Hospital Pharmacies
            13.6.3. Retail Pharmacies
     13.7.Market value Forecast By Country / Sub-region, 2015–2025
            13.7.1. China
            13.7.2. Japan
            13.7.3. India
            13.7.4. Rest of APAC
     13.8.Market Attractiveness Analysis
            13.8.1. By Vaccine Type
            13.8.2. By Valance
            13.8.3. By Route of Administration
            13.8.4. By Indication
            13.8.5. By Distribution Channel
            13.8.6. By Country / Sub-region

14. Latin America Vaccines Market Analysis and Forecast
     14.1.Introduction
            14.1.1. Key Findings
            14.1.2. Policies and Regulations
     14.2.Market value Forecast By Vaccine Type, 2015–2025
            14.2.1. Live Attenuated
            14.2.2. Inactivated
            14.2.3. Subunit & Conjugate
            14.2.4. Toxoid
            14.2.5. Others
     14.3.Market value Forecast By Valance, 2015–2025
            14.3.1. Monovalent
            14.3.2. Multivalent
     14.4.Market value Forecast By Route of Administration, 2015–2025
            14.4.1. Oral
            14.4.2. Injectable
                     14.4.2.1. Intramuscular
                     14.4.2.2. Subcutaneous
            14.4.3. Others
     14.5.Market value Forecast By Indication, 2015–2025
            14.5.1. Influenza
            14.5.2. Hepatitis
            14.5.3. Polio
            14.5.4. Meningococcal Disease
            14.5.5. Pneumococcal Disease
            14.5.6. DTP
            14.5.7. Rotavirus
            14.5.8. MMR
            14.5.9. Human Papilloma Virus
            14.5.10. Others
     14.6.Market value Forecast By Distribution Channel, 2015–2025
            14.6.1. Institutional Sale
            14.6.2. Hospital Pharmacies
            14.6.3. Retail Pharmacies
     14.7.Market value Forecast By Country / Sub-region, 2015–2025
            14.7.1. Brazil
            14.7.2. Mexico
            14.7.3. Rest of LATAM
     14.8.Market Attractiveness Analysis
            14.8.1. By Vaccine Type
            14.8.2. By Valance
            14.8.3. By Route of Administration
            14.8.4. By Indication
            14.8.5. By Distribution Channel
            14.8.6. By Country / Sub-region

15. Middle East & Africa Vaccines Market Analysis and Forecast
     15.1.Introduction
            15.1.1. Key Findings
            15.1.2. Policies and Regulations
     15.2.Market value Forecast By Vaccine Type, 2015–2025
            15.2.1. Live Attenuated
            15.2.2. Inactivated
            15.2.3. Subunit & Conjugate
            15.2.4. Toxoid
            15.2.5. Others
     15.3.Market value Forecast By Valance, 2015–2025
            15.3.1. Monovalent
            15.3.2. Multivalent
     15.4.Market value Forecast By Route of Administration, 2015–2025
            15.4.1. Oral
            15.4.2. Injectable
                     15.4.2.1. Intramuscular
                     15.4.2.2. Subcutaneous
            15.4.3. Others
     15.5.Market value Forecast By Indication, 2015–2025
            15.5.1. Influenza
            15.5.2. Hepatitis
            15.5.3. Polio
            15.5.4. Meningococcal Disease
            15.5.5. Pneumococcal Disease
            15.5.6. DTP
            15.5.7. Rotavirus
            15.5.8. MMR
            15.5.9. Human Papilloma Virus
            15.5.10. Others
     15.6.Market value Forecast By Distribution Channel, 2015–2025
            15.6.1. Institutional Sale
            15.6.2. Hospital Pharmacies
            15.6.3. Retail Pharmacies
     15.7.Market value Forecast By Country / Sub-region, 2015–2025
            15.7.1. GCC Countries
            15.7.2. South Africa
            15.7.3. Rest of MEA
     15.8.Market Attractiveness Analysis
            15.8.1. By Vaccine Type
            15.8.2. By Valance
            15.8.3. By Route of Administration
            15.8.4. By Indication
            15.8.5. By Distribution Channel
            15.8.6. By Country / Sub-region

16. Competition Landscape
     16.1.Market Player – Competition Matrix (By Tier and Size of companies)
     16.2.Market Share Analysis By Company (2016)
     16.3.Company Profiles (Details – Overview, Financials *, Recent Developments, Strategy)
            16.3.1. AstraZeneca
            16.3.2. GlaxoSmithKline plc
            16.3.3. Sanofi Pasteur SA
            16.3.4. Pfizer, Inc.
            16.3.5. Panacea Biotec
            16.3.6. Merck & Co., Inc.
            16.3.7. Janssen Pharmaceutical Company (Part of Johnson & Johnson)
            16.3.8. Serum Institute of India Ltd
            16.3.9. Emergent BioSolutions Inc.
            16.3.10. CSL
            16.3.11. Bavarian Nordic
            16.3.12. IBSS BIOMED S.A.
            16.3.13. Novavax AB
            16.3.14. Mitsubishi Tanabe Pharma Corporation

List of Tables

Table 01: Global Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 02: Global Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
Table 03: Global Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 04: Global Vaccines Market Size (US$ Mn) Forecast, by Route of Administration - InjecTable, 2015–2025
Table 05: Global Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 06: Global Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 07: Global Vaccines Market (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 09: North America Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 10: North America Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
Table 11: North America Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 12: North America Vaccines Market Size (US$ Mn) Forecast, by InjecTable, 2015–2025
Table 13: North America Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 14: North America Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 15: Europe Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 16: Europe Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 17: Europe Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
Table 18: Europe Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 19: Europe Vaccines Market Size (US$ Mn) Forecast, by InjecTable, 2015–2025
Table 20: Europe Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 21: Europe Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 22: Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 23: Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 24: Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
Table 25: Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 26: Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by InjecTable, 2015–2025
Table 27: Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 28: Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 29: Latin America Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 30: Latin America Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 31: Latin America Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
Table 32: Latin America Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 33: Latin America Vaccines Market Size (US$ Mn) Forecast, by InjecTable, 2015–2025
Table 34: Latin America Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 35: Latin America Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 36: Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 37: Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
Table 38: Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
Table 39: Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 40: Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Route of Administration - Injectable, 2015–2025
Table 41: Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 42: Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

List of Figures

Figure 01: Vaccines Market Size (US$ Mn), by Vaccine Type, 2016 (A)
Figure 02: Vaccines Market Revenue (%), by Distribution Channel, 2016 (A)
Figure 03: Global Vaccines Market Revenue (%), by Region, 2016 (A)
Figure 04: Vaccine Type Opportunity Map, 2016
Figure 05: By Valance Opportunity Map, 2016
Figure 06: By Route of Administration Opportunity Map, 2016
Figure 07: By Indication Opportunity Map, 2016
Figure 08: By Distribution Channel Opportunity Map, 2016
Figure 09: Global Vaccines Market Size (US$ Mn) Forecast, 2015–2025
Figure 10: Market Value Share, by Vaccine Type (2016)
Figure 11: Market Value Share, by Valance (2016)
Figure 12: Market Value Share, by Route of Administration (2016)
Figure 13: Market Value Share, by Distribution Channel (2016)
Figure 14: Market Value Share, by Indication (2016)
Figure 15: Market Value Share, by Region (2016)
Figure 16: Global Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
Figure 17: Global Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
Figure 18: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Inactivated Vaccines, 2015–2025
Figure 19: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Live Attenuated Vaccines, 2015–2025
Figure 20: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Toxoid Vaccine, 2015–2025
Figure 21: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Subunit & Conjugate Vaccine, 2015–2025
Figure 22: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Vaccines, 2015–2025
Figure 23: Global Vaccines Market Value Share, by Valance, 2016 and 2025
Figure 24: Global Vaccines Market Attractiveness, by Valance, 2017–2025
Figure 25: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Monovalent Vaccines, 2015–2025
Figure 26: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Multivalent Vaccines, 2015–2025
Figure 27: Global Vaccines Market Value Share, by Route of Administration, 2016 and 2025
Figure 28: Global Vaccines Market Attractiveness, by Route of Administration, 2017–2025
Figure 29: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2015–2025
Figure 30: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by InjecTable, 2015–2025
Figure 31: Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 32: Global Vaccines Market Value Share Analysis, by Indication, 2016 and 2025
Figure 33: Global Influenza Market Revenue, US$ Mn, 2017–2025
Figure 34: Global Hepatitis Market Revenue, US$ Mn, 2017–2025
Figure 35: Global Polio Market Revenue, US$ Mn, 2017–2025
Figure 36: Global Meningococcal Disease Market Revenue, US$ Mn, 2017–2025
Figure 37: Global Pneumococcal Disease Market Revenue, US$ Mn, 2017–2025
Figure 38: Global DTP Market Revenue, US$ Mn, 2017–2025
Figure 39: Global Rotavirus Market Revenue, US$ Mn, 2017–2025
Figure 40: Global MMR Market Revenue, US$ Mn, 2017–2025
Figure 41: Global Human Papillomavirus Market Revenue, US$ Mn, 2017–2025
Figure 42: Global Others Disease Market Revenue, US$ Mn, 2017–2025
Figure 43: Global Vaccines Market Attractiveness Analysis, by Indication
Figure 44: Global Vaccines Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 45: Global Institutional Sales Market Revenue, US$ Mn, 2017–2025
Figure 46: Global Hospital Pharmacies Market Revenue, US$ Mn, 2017–2025
Figure 47: Global Retail Pharmacies Market Revenue, US$ Mn, 2017–2025
Figure 48: Global Vaccines Market Attractiveness Analysis, by Distribution Channel
Figure 49: Global Vaccines Market Analysis by Region, 2016 and 2025
Figure 50: Global Vaccines Market Attractiveness Analysis, by Region
Figure 51: North America Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 52: North America Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 53: North America Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 54: North America Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
Figure 55: North America Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
Figure 56: North America Vaccines Market Value Share, by Valance, 2016 and 2025
Figure 57: North America Vaccines Market Attractiveness, by Valance, 2017–2025
Figure 58: North America Vaccines Market Value Share, by Route of Administration, 2016 and 2025
Figure 59: North America Vaccines Market Attractiveness, by Route of Administration, 2017–2025
Figure 60: North America Vaccines Market Value Share, by Indication, 2016 and 2025
Figure 61: North America Vaccines Market Attractiveness, by Indication, 2017–2025
Figure 62: North America Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
Figure 63: North America Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
Figure 64: Europe Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 65: Europe Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 66: Europe Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 67: Europe Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
Figure 68: Europe Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
Figure 69: Europe Vaccines Market Value Share, by Valance, 2016 and 2025
Figure 70: Europe Vaccines Market Attractiveness, by Valance, 2017–2025
Figure 71: Europe Vaccines Market Value Share, by Route of Administration, 2016 and 2025
Figure 72: Europe Vaccines Market Attractiveness, by Route of Administration, 2017–2025
Figure 73: Europe Vaccines Market Value Share, by Indication, 2016 and 2025
Figure 74: Europe Vaccines Market Attractiveness, by Indication, 2017–2025
Figure 75: Europe Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
Figure 76: Europe Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
Figure 77: Asia Pacific Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 78: Asia Pacific Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 79: Asia Pacific Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 80: Asia Pacific Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
Figure 81: Asia Pacific Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
Figure 82: Asia Pacific Vaccines Market Value Share, by Valance, 2016 and 2025
Figure 83: Asia Pacific Vaccines Market Attractiveness, by Valance, 2017–2025
Figure 84: Asia Pacific Vaccines Market Value Share, by Route of Administration, 2016 and 2025
Figure 85: Asia Pacific Vaccines Market Attractiveness, by Route of Administration, 2017–2025
Figure 86: Asia Pacific Vaccines Market Value Share, by Indication, 2016 and 2025
Figure 87: Asia Pacific Vaccines Market Attractiveness, by Indication, 2017–2025
Figure 88: Asia Pacific Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
Figure 89: Asia Pacific Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
Figure 90: Latin America Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 91: Latin America Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 92: Latin America Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 93: Latin America Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
Figure 94: Latin America Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
Figure 95: Latin America Vaccines Market Value Share, by Valance, 2016 and 2025
Figure 96: Latin America Vaccines Market Attractiveness, by Valance, 2017–2025
Figure 97: Latin America Vaccines Market Value Share, by Route of Administration, 2016 and 2025
Figure 98: Latin America Vaccines Market Attractiveness, by Route of Administration, 2017–2025
Figure 99: Latin America Vaccines Market Value Share, by Indication, 2016 and 2025
Figure 100: Latin America Vaccines Market Attractiveness, by Indication, 2017–2025
Figure 101: Latin America Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
Figure 102: Latin America Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
Figure 103: Middle East & Africa Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 104: Middle East & Africa Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 105: Middle East & Africa Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 106: Middle East & Africa Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
Figure 107: Middle East & Africa Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
Figure 108: Middle East & Africa Vaccines Market Value Share, by Valance, 2016 and 2025
Figure 109: Middle East & Africa Vaccines Market Attractiveness, by Valance, 2017–2025
Figure 110: Middle East & Africa Vaccines Market Value Share, by Route of Administration, 2016 and 2025
Figure 111: Middle East & Africa Vaccines Market Attractiveness, by Route of Administration,  2017–2025
Figure 112: Middle East & Africa Vaccines Market Value Share, by Indication, 2016 and 2025
Figure 113: Middle East & Africa Vaccines Market Attractiveness, by Indication, 2017–2025
Figure 114: Middle East & Africa Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
Figure 115: Middle East & Africa Vaccines Market Attractiveness, by Distribution Channel, 2017-2025
Figure 116: Global Vaccines Market Share Analysis, by Company (2016)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

463

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved